Suzhou, China

Yijie Dong

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yijie Dong: Innovator in Lipid Nanoparticle and Polynucleotide Technologies

Introduction

Yijie Dong is a prominent inventor based in Suzhou, China. He has made significant contributions to the fields of lipid compounds and polynucleotide technologies. With a total of 3 patents to his name, Dong is recognized for his innovative approaches to delivering active agents and addressing HPV-related diseases.

Latest Patents

One of Yijie Dong's latest patents involves lipid compounds and lipid nanoparticle compositions. This application discloses a compound of formula (I) and its salts and stereoisomers, along with a nanoparticle composition that utilizes these compounds for effective delivery of active agents. Another notable patent focuses on polynucleotide molecules that can be used for the prevention or treatment of HPV infection-related diseases. This application details a polynucleotide molecule that can be incorporated into pharmaceutical products, compositions, or mRNA vaccines aimed at combating HPV-related health issues.

Career Highlights

Throughout his career, Yijie Dong has worked with various organizations, including Rinuagene Biotechnology Co., Ltd. and Rinuagene International HK Limited. His work in these companies has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology.

Collaborations

Yijie Dong has collaborated with notable colleagues such as Shan Cen and Kai Lv. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biotechnology.

Conclusion

Yijie Dong's contributions to lipid nanoparticle and polynucleotide technologies highlight his role as an influential inventor in the biotechnology sector. His innovative patents and collaborations continue to pave the way for advancements in medical treatments and drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…